19 January 2017
News and Views
Links and Services
This month's American Journal of Gastroenterology reports that Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
Fecal immunochemical testing (FIT) is increasingly used for colorectal cancer (CRC) screening.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors